tiprankstipranks
pc:pepti

Pepticom

Pepticom is a leader in AI-driven peptide-based therapeutics, focusing on the development of innovative treatments for autoimmune diseases. The company is advancing its oral IL-17 inhibitor program, which includes the design of synthetic, small cyclic peptidomimetic inhibitors targeting IL-17A and IL-17F isoforms. These compounds, composed of non-natural amino acids, offer enhanced stability and extended half-life, marking significant progress in next-generation drug discovery.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$7M
Total Amount Raised$7M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$7M
Latest Funding Amount$7M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 07, 2025
Series A
$6.60M

Investors

Investor Name
Funding Round

Related News and Analysis